FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1838931625> ?p ?o ?g. }

• W1838931625 endingPage "2548" @default.
• W1838931625 startingPage "2541" @default.
• W1838931625 abstract "The low-dose (0.6 mg/kg) alteplase strategy to treat acute ischemic stroke patients became widespread in East Asian countries, without rigorous testing against standard-dose (0.9 mg/kg) alteplase treatment. Our aim was to investigate the comparative effectiveness and safety of the low-dose versus standard-dose intravenous alteplase strategy.A total of 1526 acute ischemic stroke patients who qualified for intravenous alteplase and treated within 4.5 hours were identified from a prospective, multicenter, and nationwide stroke registry database. Primary outcomes were a modified Rankin scale score of 0 to 1 at 3 months after stroke and occurrence of symptomatic hemorrhagic transformation. Inverse probability of low-dose alteplase weighting by propensity scores was used to remove baseline imbalances between the 2 groups, and variation among centers were also accounted using generalized linear mixed models with a random intercept.Low-dose intravenous alteplase was given to 450 patients (29.5%) and standard-dose intravenous alteplase to 1076 patients (70.5%). Low-dose alteplase treatment was comparable to standard-dose therapy according to the following adjusted outcomes and odds ratios (95% confidence intervals): modified Rankin scale score 0 to 1 at 3 months and 0.95 (0.68-1.32); modified Rankin scale 0 to 2 at 3 months and 0.84 (0.62-1.15); symptomatic hemorrhagic transformation and 1.05 (0.65-1.70); and 3-month mortality and 0.54 (0.35-0.83). The associations were unchanged when the analysis was limited to those without endovascular recanalization.The low-dose alteplase strategy was comparable to the standard-dose treatment in terms of the effectiveness and safety." @default.
• W1838931625 created "2016-06-24" @default.
• W1838931625 creator A5000627464 @default.
• W1838931625 creator A5007611070 @default.
• W1838931625 creator A5009410494 @default.
• W1838931625 creator A5013559060 @default.
• W1838931625 creator A5013808765 @default.
• W1838931625 creator A5019914929 @default.
• W1838931625 creator A5022150256 @default.
• W1838931625 creator A5024940863 @default.
• W1838931625 creator A5027700402 @default.
• W1838931625 creator A5029061981 @default.
• W1838931625 creator A5030337320 @default.
• W1838931625 creator A5033463484 @default.
• W1838931625 creator A5035023285 @default.
• W1838931625 creator A5035547791 @default.
• W1838931625 creator A5037219800 @default.
• W1838931625 creator A5038364929 @default.
• W1838931625 creator A5041894132 @default.
• W1838931625 creator A5052508004 @default.
• W1838931625 creator A5067050371 @default.
• W1838931625 creator A5071829277 @default.
• W1838931625 creator A5072472240 @default.
• W1838931625 creator A5077437724 @default.
• W1838931625 creator A5083951183 @default.
• W1838931625 creator A5084674542 @default.
• W1838931625 creator A5088274241 @default.
• W1838931625 creator A5088824391 @default.
• W1838931625 creator A5090733758 @default.
• W1838931625 date "2015-09-01" @default.
• W1838931625 modified "2023-10-18" @default.
• W1838931625 title "Low-Versus Standard-Dose Alteplase for Ischemic Strokes Within 4.5 Hours" @default.
• W1838931625 cites W1601856245 @default.
• W1838931625 cites W1972753581 @default.
• W1838931625 cites W2006566363 @default.
• W1838931625 cites W2008557562 @default.
• W1838931625 cites W2009187570 @default.
• W1838931625 cites W2013606890 @default.
• W1838931625 cites W2036046842 @default.
• W1838931625 cites W2043976791 @default.
• W1838931625 cites W2046629096 @default.
• W1838931625 cites W2052567024 @default.
• W1838931625 cites W2060969842 @default.
• W1838931625 cites W2094508973 @default.
• W1838931625 cites W2119542322 @default.
• W1838931625 cites W2122396373 @default.
• W1838931625 cites W2127673268 @default.
• W1838931625 cites W2134863928 @default.
• W1838931625 cites W2136587148 @default.
• W1838931625 cites W2139621750 @default.
• W1838931625 cites W2141844318 @default.
• W1838931625 cites W2143004298 @default.
• W1838931625 cites W2150291618 @default.
• W1838931625 cites W2150360466 @default.
• W1838931625 cites W2153859061 @default.
• W1838931625 cites W2159915255 @default.
• W1838931625 cites W2164763924 @default.
• W1838931625 cites W2167894791 @default.
• W1838931625 cites W2171058244 @default.
• W1838931625 cites W2171165037 @default.
• W1838931625 cites W2419262315 @default.
• W1838931625 cites W2531503442 @default.
• W1838931625 doi "https://doi.org/10.1161/strokeaha.115.010180" @default.
• W1838931625 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26243232" @default.
• W1838931625 hasPublicationYear "2015" @default.
• W1838931625 type Work @default.
• W1838931625 sameAs 1838931625 @default.
• W1838931625 citedByCount "47" @default.
• W1838931625 countsByYear W18389316252015 @default.
• W1838931625 countsByYear W18389316252016 @default.
• W1838931625 countsByYear W18389316252017 @default.
• W1838931625 countsByYear W18389316252018 @default.
• W1838931625 countsByYear W18389316252019 @default.
• W1838931625 countsByYear W18389316252020 @default.
• W1838931625 countsByYear W18389316252021 @default.
• W1838931625 countsByYear W18389316252022 @default.
• W1838931625 countsByYear W18389316252023 @default.
• W1838931625 crossrefType "journal-article" @default.
• W1838931625 hasAuthorship W1838931625A5000627464 @default.
• W1838931625 hasAuthorship W1838931625A5007611070 @default.
• W1838931625 hasAuthorship W1838931625A5009410494 @default.
• W1838931625 hasAuthorship W1838931625A5013559060 @default.
• W1838931625 hasAuthorship W1838931625A5013808765 @default.
• W1838931625 hasAuthorship W1838931625A5019914929 @default.
• W1838931625 hasAuthorship W1838931625A5022150256 @default.
• W1838931625 hasAuthorship W1838931625A5024940863 @default.
• W1838931625 hasAuthorship W1838931625A5027700402 @default.
• W1838931625 hasAuthorship W1838931625A5029061981 @default.
• W1838931625 hasAuthorship W1838931625A5030337320 @default.
• W1838931625 hasAuthorship W1838931625A5033463484 @default.
• W1838931625 hasAuthorship W1838931625A5035023285 @default.
• W1838931625 hasAuthorship W1838931625A5035547791 @default.
• W1838931625 hasAuthorship W1838931625A5037219800 @default.
• W1838931625 hasAuthorship W1838931625A5038364929 @default.
• W1838931625 hasAuthorship W1838931625A5041894132 @default.
• W1838931625 hasAuthorship W1838931625A5052508004 @default.
• W1838931625 hasAuthorship W1838931625A5067050371 @default.
• W1838931625 hasAuthorship W1838931625A5071829277 @default.

• next